QualityStocksNewsBreaks Archives - Page 2 of 1625

FridaySep 11, 2026 10:22 am

QualityStocksNewsBreaks – Nanox Imaging Ltd. (NASDAQ: NNOX) Signs Nanox.ARC Distribution Agreement for Costa Rica

Nanox (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. SOLME will oversee marketing, distribution, installation, training and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (“CCSS”), the country principal purchaser and provider of hospital services. Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration, and Costa Rica represents Nanox third Latin American market this year…

FridaySep 11, 2026 9:20 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Featured in BioMedWire Editorial on Lucid-MS Phase 2 Trial

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) announced its placement in a BioMedWire editorial examining the potential of Lucid-MS to address limitations of existing multiple sclerosis (“MS”) treatments. The editorial highlights Quantum BioPharma’s U.S. Food and Drug Administration (“FDA”) clearance to launch a phase 2 trial of Lucid-MS, a patented, first-in-class candidate designed to protect and potentially rebuild the myelin sheath rather than suppress the immune system. According to the publication, the trial would mark the first time a drug based on this mechanism is tested in people…

ThursdaySep 10, 2026 1:06 pm

QualityStocksNewsBreaks – AmpliTech Group, Inc. (NASDAQ: AMPG, AMPGZ) Receives $7.3 Million in Follow-On Orders for Asian 5G O-RAN Deployment

AmpliTech Group (NASDAQ: AMPG, AMPGZ) received approximately $7.3 million in follow-on orders supporting deployments for an Asian mobile network operator (“MNO”) under its previously announced 5G O-RAN radio Letter of Intent (“LOI”) program. The orders follow deployment of AmpliTech O-RAN radios at end-customer 5G sites and represent renewed purchasing activity under the program. The company said the orders, together with recently received follow-on orders supporting its North American MNO program, restore momentum under the LOI program and support its efforts to convert its opportunity pipeline into shipments and revenue. To view the full press release, visit https://ibn.fm/p85ry About AmpliTech Group, Inc. AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGZ)…

ThursdaySep 10, 2026 1:05 pm

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Bolsters Scientific Leadership Ahead of BiTAC(R) Clinical Development

VERAXA Biotech (NASDAQ: VRXA) recently appointed antibody therapeutics specialist Dr. Christoph Erkel as its chief scientific officer, taking responsibility for advancing the company’s proprietary BiTAC(R) technology and broader oncology pipeline toward clinical development. The company’s lead BiTAC-TCE program uses a conditionally active, dual-targeting approach designed to selectively activate T cells against cancer cells while potentially limiting effects on healthy tissue. Recent scientific advice from Germany’s Paul-Ehrlich-Institute provided additional clarity around the program’s proposed non-clinical development strategy, while preclinical data presented at the AACR Annual Meeting showed selective activity against cells expressing both target molecules. Beyond BiTAC, VERAXA is developing bispecific antibody-drug…

ThursdaySep 10, 2026 12:37 pm

QualityStocksNewsBreaks – Silver Bow Mining Corp. (NYSE American: SBMT) Receives Bankruptcy Court Approval, Completes Initial Closing for Jefferson County Metallurgical Complex

Silver Bow Mining (NYSE American: SBMT) announced that the U.S. Bankruptcy Court for the District of Montana approved the sale of specified Montana Tunnels Mining assets comprising the Jefferson County Metallurgical Complex to Silver Bow and its wholly owned subsidiary, Silver Bow Tunnels Corp. The company also completed the initial closing under its previously announced definitive asset purchase agreement after funding approximately $28.58 million into escrow to satisfy specified creditor obligations, including approximately $4.27 million owed to Jefferson County and $20.78 million in specified obligations to the Montana Department of Environmental Quality. The initial closing does not transfer ownership of the Complex to Silver Bow. The company…

ThursdaySep 10, 2026 12:24 pm

QualityStocksNewsBreaks – Perpetuals.com Ltd. (NASDAQ: PDC) Launches Joint AI Trading Research Group with European Institute of Management

Perpetuals.com (NASDAQ: PDC) and the European Institute of Management (“EIM”) launched a joint research group pairing more than 20 doctoral researchers with Perpetuals to develop AI-powered trading models combining machine learning and crowd intelligence. The researchers will have access to Perpetuals proprietary trading datasets and live venue data, with work focused on behavioral finance, trader performance classification, market microstructure and model risk. The initiative is expected to run for at least three years, with more than half of the participating researchers currently employed by Perpetuals. To view the full press release, visit https://ibn.fm/xSf7A About Perpetuals Perpetuals.com Ltd (NASDAQ: PDC) is a fintech company developing…

ThursdaySep 10, 2026 12:17 pm

QualityStocksNewsBreaks – Earth Science Tech Inc.’s (ETST) B2B-B2C Healthcare Platform Powers Continued Revenue Growth

Earth Science Tech (OTC: ETST) is positioning itself as a vertically integrated healthcare company through its subsidiaries RxCompoundStore, Mister Meds, and Peaks Curative, combining compounding pharmacy, telemedicine, clinical support, and fulfillment capabilities. Its B2B and B2C business model allows the company to serve independent clinics while also selling customized medications directly to consumers, creating diversified revenue streams across physical and digital healthcare operations. In FY2026, ETST reported revenue of $35.7 million, up from $33.1 million in FY2025 and $11.95 million in FY2024, while also reporting positive operating cash flow and a stronger balance sheet. The company reduced total liabilities from $3.146…

ThursdaySep 10, 2026 10:10 am

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) Launches Overwatch Patrol for GPS-Denied Dismounted Operations

This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) launched Overwatch Patrol, a dismounted positioning application designed to provide continuous location information to soldiers and security personnel when GPS is jammed, spoofed, degraded or unavailable. Unveiled at the International Defense Industry Exhibition (“MSPO”) in Kielce, Poland, Overwatch Patrol operates through the company’s cloud-based Overwatch Positioning Network without additional hardware and can be delivered through a native application or standard web browser. The platform enables multiple team members to share live positions without GPS and allows…

ThursdaySep 10, 2026 10:00 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) Advances Lucid-MS Toward Phase 2 Trial Following FDA Clearance

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) is advancing Lucid-MS toward a randomized, double-blind, placebo-controlled phase 2 trial in multiple sclerosis (“MS”) following U.S. Food and Drug Administration (“FDA”) clearance of its Investigational New Drug (“IND”) application. Lucid-MS is a patented, first-in-class, non-covalent inhibitor of peptidyl arginine deiminase 2 (“PAD2”) designed to target demyelination directly rather than suppress the immune system. The editorial also highlights Quantum BioPharma research collaboration with Massachusetts General Hospital and Harvard Medical School involving the [¹⁸F]3F4AP PET imaging tracer, which is being evaluated as a…

ThursdaySep 10, 2026 9:52 am

QualityStocksNewsBreaks – American Fusion Inc. (OTC: AMFN) Highlights Texatron(TM) Fusion Engine(TM) Development, AI Power Strategy in New Interview

American Fusion (OTC: AMFN) announced the release of a new AGORACOM interview featuring Executive Chairman Brent Nelson discussing development of the company proprietary Texatron(TM) Fusion Engine(TM) and its strategy for addressing growing electricity demand from artificial intelligence, data centers and other power-intensive applications. Nelson discusses the company 5 MW preproduction Texatron(TM), plans for 10 MW and 20 MW systems and Texas authorization to test 12 planned system sizes ranging from approximately 500 kW to 1 GW, while noting the ratings are intended system sizes and not demonstrated electrical output. American Fusion is targeting documented test results demonstrating the Texatron(TM) can generate and capture sufficient energy for conversion into usable electricity, with…

Site Search

Company Search

Category: QualityStocksNewsBreaks